Bormioli Pharma and Pierre Fabre develop a 100% recycled PET packaging
25 October 2022
Parma (Italy), Castres (France), Tuesday, 25th October 2022 – Bormioli Pharma - international leader in the production of containers for the pharmaceutical industry, and Pierre Fabre, a French pharmaceutical and dermo-cosmetic group present in more than 100 countries, are consolidating their partnership started in 2020 through an innovative initiative in eco-design and sustainable development.
The two companies have developed an innovative 100% recycled PET packaging for the mouthwashes of the ELUDRIL® brand, one of the European leaders in oral care in the pharmacy channel. ELUDRIL® mouthwashes thus are among the first oral hygiene products in Europe to benefit from this type of packaging. This achievement is the result of a prospecting process conducted with ten different suppliers of recyclable PET in order to find the solution meeting the requirements of Pierre Fabre in terms of machinability, safety for the consumer, aesthetics and regulatory compliance. In addition to the use of recycled plastic, the new packaging is also lighter than its old packaging, which reduces the consumption of raw materials. Thanks to this innovation, more than one ton of plastic will be saved each year.
This initiative reflects the shared commitment of the two companies to sustainable development, a fundamental pillar for both Bormioli Pharma, which has committed to manufacture 50% of its products from materials with low environmental impact by 2025, and for Pierre Fabre, who has pledged as part of his Green Mission that 50% of his dermo-cosmetic and oral hygiene portfolio will be eco-social-designed by 2023.
The historic collaboration with a group as important and recognized as Pierre Fabre is a source of pride and inspiration for us. We are delighted with the excellent results we have achieved together on the new packaging for ELUDRIL®, one of Europe's best-selling oral care products, which could well pave the way for the widespread adoption of recycled PET in this sector. For our part, we continue to innovate and improve, aiming to meet the most stringent quality and safety requirements in the industry, in order to provide even greater satisfaction to our customers.
With our teams, we conduct a daily reflection to eco-design our packaging in order to improve its environmental performance from the design and throughout its life cycle. Our partnership with Bormioli Pharma reinforces our common commitment to implement concrete and measurable actions in favour of sustainable development, an approach at the heart of our responsible innovation approach, carried with the Pierre Fabre Green Mission.
Pierre Fabre has also chosen sustainable packaging designed and manufactured by Bormioli Pharma for its dermo-cosmetic brands Eau Thermale Avène, Ducray, René Furterer, Klorane and A-Derma. A majority of Bormioli Pharma's packaging used by Pierre Fabre is manufactured in the Saint-Sulpice (Tarn) factory, less than 50 kilometres away from Pierre Fabre's main dermo-cosmetic production factory. This short circuit reduces CO2 emissions and road pollution caused by the transport of packaging.
To evaluate the environmental and societal impact of dermo-cosmetic and family health products, and to communicate transparently on this impact to consumers, Pierre Fabre launched the Green Impact Index in June 2021, a tool based on the evaluation of 20 criteria. Among the criteria used to assess the environmental impact is the eco-design of the packaging, which is based on seven variables such as recyclability and the integration of recycled materials in its composition. Thanks to the technologies and tools it develops in these two areas, Bormioli Pharma is making a concrete way to the continuous improvement of the Pierre Fabre Green Impact Index.
About Bormioli Pharma
Bormioli Pharma works closely with the pharmaceutical industry and all companies that are working towards the future of healthcare globally. As a world-renowned player in the packaging industry, the company serves the pharmaceutical and biopharmaceutical markets with complete solutions, including glass and plastic bottles, plastic and aluminum closures and accessories. Bormioli Pharma’s wide product ranges are designed and manufactured looking forward innovation and addressing ever-growing sustainability issues. Moreover, each product is specifically conceived for the destination market thanks to an accurate portfolio segmentation. Bormioli Pharma has a global presence in over 100 countries, with more than 1,400 employees and 9 plants across Europe specialized in the production of glass and plastic packaging. Each year, the company produces more than 7 billion pieces and in 2021 reported annual sales of approximately 260 million euros. As a partner to the pharmaceutical industry, Bormioli Pharma invests and innovates with one goal in mind: making health a positive practice, available to everyone, kind to the planet.
About Pierre Fabre
Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private pharmaceutical group in France. Its portfolio includes several medical franchises and international brands, including Pierre Fabre Oncology, Pierre Fabre Dermatology, Eau Thermale Avène, Klorane, Ducray, René Furterer, A-Derma, Darrow, Glytone, Naturactive and Pierre Fabre Oral Care. In 2021, Pierre Fabre posted 2.5 billion euros in revenues, 66% of which came from international sales in over 100 countries. Established in the South-West of France since its creation, and manufacturing over 95% of its products in France, the Group employs some 9,500 people worldwide. 86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation since 1999, and secondarily by its employees via an employee stock ownership plan.
Pierre Fabre's social responsibility approach has been assessed by the independent organisation AFNOR Certification at the "Exemplary" level of the CSR label (ISO 26 000 standard for sustainable development).
www.pierre-fabre.com, @PierreFabre
About Green Mission
This is the CSR and sustainable development policy of the Pierre Fabre Group. Green Mission Pierre Fabre has chosen a climate strategy aligned with the +2° trajectory of the 2015 Paris agreements by aiming for a 20% reduction in water consumption by 2024 (compared to 2018) and a 30% reduction in CO2 emissions or a 25% reduction in energy consumption by 2025 (compared to 2015).
For further information: